Genetics, genomics and proteomics
.png "Michael Brenner, MD photo")
Michael Brenner, MD
Brigham and Women's Hospital, Harvard Medical School
Newton, MA, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
This session will share current evidence-based research on the role of epigenetic mechanisms and their contribution to disease onset or progression in rheumatic diseases. Faculty will provide the most recent perspective on DNA methylation, histone modifications, and abnormal expression of non-coding RNAs, including microRNA, and discuss how new findings clearly indicate their high diagnostic potential and promise as a therapeutic target in the treatment of rheumatic conditions such as rheumatoid arthritis, osteoarthritis, and gout.
Speaker: Nunzio Bottini, MD, PhD – Cedars Sinai Medical Center
Speaker: Eliza Pei-Suen Tsou, PhD – University of Michigan
Speaker: Nidhi Bhutani, PhD – Stanford University
